Ka. Virtanen et al., CHRONIC TREATMENT WITH BRL-35135 POTENTIATES THE ACTION OF INSULIN ONLIPID-METABOLISM, European journal of pharmacology, 332(2), 1997, pp. 215-218
The effects of a beta(3)-adrenoceptor agonist on insulin-induced chang
es in lipid metabolism were studied in obese male Zucker (fa/fa) rats
during euglycaemic clamp. Rats were treated with BRL 35135 -chlorophen
yl)-ethyl-amino]-propyl]-phenoxyacetate hydrobromide) (0.5 mg/kg per d
ay in drinking water) for three weeks before an euglycaemic hyperinsul
inaemic clamp was performed. Insulin infusion lowered serum non-esteri
fied fatty acids and plasma glycerol more efficiently in BRL 35135-tre
ated than in control rats although plasma insulin remained significant
ly lower in the BRL 35135-treated than in the control rats during the
clamp. In conclusion, chronic treatment with BRL 35135 potentiates the
effect of insulin on lipid metabolism. (C) 1997 Elsevier Science B.V.